Merck (MRK)

Merck (MRK) – FDA

Apr 4, 2024 06:45 AM Merck (MRK) Initiates Phase 3 Clinical Trial of MK-1084
Apr 3, 2024 08:04 AM Daiichi Sankyo and Merck (MRK) Announce REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer
Mar 28, 2024 06:46 AM
Mar 26, 2024 05:14 PM
Mar 21, 2024 06:45 AM
Mar 19, 2024 09:02 AM
Mar 15, 2024 06:45 AM
Mar 12, 2024 06:01 AM
Mar 11, 2024 10:21 AM
Mar 6, 2024 10:25 AM
Feb 23, 2024 06:23 AM
Feb 23, 2024 06:21 AM
Feb 20, 2024 06:45 AM
Jan 29, 2024 05:54 AM
Jan 26, 2024 10:00 AM
Jan 12, 2024 04:36 PM
Jan 5, 2024 06:46 AM
Dec 22, 2023 08:01 AM
Dec 21, 2023 04:15 PM
Dec 20, 2023 04:30 PM
Dec 19, 2023 06:45 AM
Dec 18, 2023 06:45 AM
Dec 15, 2023 05:00 PM
Dec 15, 2023 03:34 AM
Dec 14, 2023 10:38 AM
Dec 14, 2023 06:32 AM
Dec 11, 2023 07:00 AM
Dec 11, 2023 06:56 AM
Dec 7, 2023 06:51 AM
Dec 7, 2023 06:06 AM
Nov 28, 2023 06:48 AM
Nov 16, 2023 05:41 PM
Nov 15, 2023 12:31 PM
Nov 14, 2023 08:02 AM
Nov 10, 2023 07:41 AM
Nov 1, 2023 06:46 AM
Oct 20, 2023 08:03 AM
Oct 20, 2023 07:41 AM
Oct 20, 2023 07:07 AM
Oct 17, 2023 06:45 AM
Oct 16, 2023 07:36 PM
Oct 16, 2023 06:45 AM
Oct 13, 2023 07:45 AM
Oct 10, 2023 06:46 AM
Oct 10, 2023 06:31 AM
Oct 5, 2023 07:01 AM
Sep 28, 2023 06:46 AM
Sep 22, 2023 06:46 AM
Sep 22, 2023 06:00 AM
Sep 20, 2023 06:45 AM